Abstract:Researchers and clinicians often rely on molecular assays like PCR to identify and monitor viral infections, instead of the resource-prohibitive gold standard of viral culture. However, it remains unclear when (if ever) PCR measurements of viral load are reliable indicators of replicating or infectious virus. The recent popularity of PCR protocols targeting subgenomic RNA for SARS-CoV-2 has caused further confusion, as the relationships between subgenomic RNA and standard total RNA assays are incompletely characterized and opinions differ on which RNA type better predicts culture outcomes. Here, we explore these issues by comparing total RNA, subgenomic RNA, and viral culture results from 24 studies of SARS-CoV-2 in non-human primates (including 2167 samples from 174 individuals) using custom-developed Bayesian statistical models. On out-of-sample data, our best models predict subgenomic RNA positivity from total RNA data with 91% accuracy, and they predict culture positivity with 85% accuracy. Further analyses of individual time series indicate that many apparent prediction errors may arise from issues with assay sensitivity or sample processing, suggesting true accuracy may be higher than these estimates. Total RNA and subgenomic RNA showed equivalent performance as predictors of culture positivity. Multiple cofactors (including exposure conditions, host traits, and assay protocols) influence culture predictions, yielding insights into biological and methodological sources of variation in assay outcomes–and indicating that no single threshold value applies across study designs. We also show that our model can accurately predict when an individual is no longer infectious, illustrating the potential for future models trained on human data to guide clinical decisions on case isolation. Our work shows that meta-analysis of in vivo data can overcome longstanding challenges arising from limited sample sizes and can yield robust insights beyond those attainable from individual studies. Our analytical pipeline offers a framework to develop similar predictive tools in other virus-host systems, including models trained on human data, which could support laboratory analyses, medical decisions, and public health guidelines. Although viral culture is the gold-standard method to detect replicating and infectious virus, decisions in virology research, clinical diagnostics, and public health often must rely on faster, cheaper PCR assays that detect viral genetic material. Substantial scientific effort has focused on assessing whether PCR assays (and what kind of PCR assays) can accurately predict culture outcomes, often finding conflicting results. In our study, we address this long-standing question by developing a customized statistical approach to analyze a large database of non-human primates experimentally infected with SARS-CoV-2. We demonstrate that two common PCR protocols can predict viral culture results with similarly high accuracy, as long as interpretations account for other factors such as exposure conditions, demographics, and assay protocols. For example, we show that inoculated tissues are more likely to be culture-positive (for a given PCR result) on the first day post infection than all later days post infection or non-inoculated tissue on any day–a finding that will clarify interpretation of results in experimental studies. Beyond these biological findings, we also showed that our framework can accurately identify when an individual is no longer infectious, showing the potential for future versions (trained on human data) to offer an individualized approach to ending isolation. Overall, our work presents a standardized framework to quantitatively predict viral culture outcomes based on faster and cheaper assays, which can be readily adapted to any other pathogen-host system with relevant data. Our work also demonstrates the power of (Bayesian) meta-analysis, which will be essential for the new era of data sharing in virology.

Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates

CRISPR-based Assay Reveals SARS-CoV-2 RNA Dynamic Changes and Redistribution Patterns in Non-Human Primate Model

A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method

Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral elimination

Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection

Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applications

Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2

Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression

Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern

Identifying and prioritizing potential human-infecting viruses from their genome sequences

A joint Bayesian hierarchical model for estimating SARS-CoV-2 diagnostic and subgenomic RNA viral dynamics and seroconversion

Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19

Major Shortcomings of the First Who-Recommended RT-QPCR to 'Detect' SARS-CoV-2 and to 'Diagnose' COVID-19. NGS Provides Evidence that Successive Waves of SARS-CoV-2 Variants Lack Genomic Relationship

Validation of an unbiased metagenomic detection assay for RNA viruses in viral transport media and plasma

Integrative genomic analysis of the lung tissue microenvironment in SARS-CoV-2 and NL63 patients

Reimagining the serocatalytic model for infectious diseases: a case study of common coronaviruses

A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants

Analysis of Bacteriophage Behavior of a Human RNA Virus, SARS-CoV-2, through the Integrated Approach of Immunofluorescence Microscopy, Proteomics and D-Amino Acid Quantification

Optimisation of SARS-CoV-2 culture from clinical samples for clinical trial applications

AIVE: accurate predictions of SARS-CoV-2 infectivity from comprehensive analysis

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models